Clinical Trials Logo

Clinical Trial Summary

Skin prick test (SPT) was used for diagnostic test for type 1 hypersensitivity. The efficacy and safety of SPT were proved. The positive control of SPT is histamine.

In Thailand, the most common concentration of histamine for SPT is 10 mg/ml. However, in some practice they use other concentration (1, 2.5 mg/ml).

This study will find the proper concentration of histamine for positive control use in SPT.


Clinical Trial Description

Appropriate concentration of histamine positive control is important in interpretation the result of skin prick test. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02561429
Study type Interventional
Source Mahidol University
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date August 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06065137 - Standardised Drug Provocation Testing in Perioperative Hypersensitivity N/A
Completed NCT00850668 - Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults Phase 1
Completed NCT02561390 - Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens N/A
Completed NCT00461097 - Oral Immunotherapy for Childhood Egg Allergy Phase 2
Completed NCT01084174 - A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Phase 1/Phase 2
Completed NCT01407640 - Diagnosis and Physiopathology of Insulin Allergy N/A
Completed NCT00580606 - A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Phase 1/Phase 2